Peptides

Compounds & Therapies

5-Amino-1MQ — NNMT Inhibitor

5-Amino-1-methylquinolinium iodide (5-amino-1MQ) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide using S-adenosylmethionine (SAM) as a methyl donor. Two metabolic problems flow from…

AOD-9604

Failed Drug Candidate With Misleading GRAS Status

ARA-290 (Cibinetide)

Innate Repair Receptor Agonist in Phase 2 Development

BPC-157

Emerging Peptide for Tissue Repair Research

BPC-157 (Body Protection Compound-157): A Practical Guide

Cartalax — Khavinson Short-Peptide Bioregulator for Cartilage

Cartalax (Ala-Glu-Asp, AED tripeptide) is one of approximately fifteen short-peptide bioregulators developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology beginning in the 1970s. The Khavinson…

Cerebrolysin

Cerebrolysin is a parenteral pharmaceutical preparation of low-molecular-weight peptides and free amino acids derived from enzymatically processed porcine brain tissue. Manufactured by EVER Pharma since the 1970s, it is approved in more than 40…

CJC-1295

Long-Acting GHRH Analog for GH Secretion Research

CJC-1295: A Practical Guide

Dihexa

Angiotensin IV Analog With No Human Safety Data

DSIP — Delta Sleep-Inducing Peptide

Delta sleep-inducing peptide (DSIP) is a small (nine amino acid) neuropeptide first identified in 1977 by Monnier and colleagues in Switzerland, isolated from the cerebral venous blood of rabbits exposed to electrical stimulation that induced…

Epitalon

Unproven Telomerase Activator From Russia

Epitalon (Epithalon): A Practical Guide

Follistatin (FST-344)

Follistatin is a glycoprotein that binds and neutralizes myostatin (GDF-8), activin A, and several bone morphogenetic proteins. Because myostatin is the dominant brake on skeletal-muscle growth, blocking myostatin produces dramatic muscle…

GHK-Cu (Copper Peptide)

Cosmetic Peptide With Topical Benefits and Injectable Research Status

GHK-Cu (Copper Tripeptide): A Practical Guide

GHRP-2 (Growth Hormone Releasing Peptide-2): A Practical Guide

GHRP-6: A Practical Guide

Hexarelin

Hexarelin is a synthetic hexapeptide growth hormone-releasing peptide (GHRP) developed in the early 1990s as part of the GHRP-2/GHRP-6/hexarelin family. At equivalent doses, hexarelin produces growth hormone pulses larger than GHRP-2 or GHRP-6,…

IGF-LR3 (Insulin-Like Growth Factor-1 Long Arg3)

Potent Modified IGF-1 With Extreme Abuse Potential

Ipamorelin

Selective GH Secretagogue for Research Use

Ipamorelin: A Practical Guide

Kisspeptin

Investigational Reproductive Peptide in Active Research

KPV (Lysine-Proline-Valine)

Tripeptide Fragment With Zero Human Evidence

LL-37

Human Cathelicidin Antimicrobial Peptide (Preclinical Only)

MOTS-c (Mitochondrial Open Reading Frame of the 12S rRNA Type-c): A Practical Guide

MOTS-c (Mitochondrial-Derived Peptide)

Preclinical Mitochondrial Peptide With Theoretical Metabolic Benefits

N-Acetyl Semax and N-Acetyl Selank

Semax (a synthetic analog of the N-terminal fragment of ACTH 4-10) and Selank (a synthetic analog of tuftsin) were developed by Russian scientific research institutes beginning in the 1980s-1990s. Both are registered medications in Russia for…

Pinealon

Pinealon (Glu-Asp-Arg) is a synthetic tripeptide developed by Vladimir Khavinson and colleagues at the St. Petersburg Institute of Bioregulation and Gerontology. It is part of the broader Khavinson 'short peptide' bioregulator program, which has…

PT-141 (Bremelanotide)

FDA-Approved Melanocortin Agonist (Women Only)

PT-141 (Bremelanotide): A Practical Guide

Selank

Russian-Approved Anxiolytic Peptide (Tuftsin Analog)

Semax

Russian-Approved Neuroprotective Peptide (ACTH Analog)

Sermorelin

FDA-Approved GHRH Analog (Discontinued Commercially, Available via Compounding)

Sermorelin: A Practical Guide

SS-31 (Elamipretide)

Investigational Mitochondrial Protective Peptide in Active Development

TB-500 (Thymosin Beta-4 Fragment): A Practical Guide

TB-500 (Thymosin Beta-4)

Actin-Binding Peptide Under Scrutiny

Tesamorelin

FDA-Approved GHRH Analog for HIV-Associated Lipodystrophy

Thymosin Alpha-1

Approved in 35+ Countries (Except US, EU, UK, Australia, Canada)

Thymosin Beta-4 (Tβ4): A Practical Guide

Thymulin: A Practical Guide

VIP (Vasoactive Intestinal Peptide)

Endogenous Neuropeptide With Limited Clinical Evidence for CIRS

V
Vanguard AI
Research Assistant
Feedback